Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Future 3-5Y EPS without NRI Growth Rate : 86.55 (As of May. 29, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Chengdu Olymvax Biopharmaceuticals Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Chengdu Olymvax Biopharmaceuticals's Future 3-5Y EPS without NRI Growth Rate is 86.55.

Competitive Comparison of Chengdu Olymvax Biopharmaceuticals's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, Chengdu Olymvax Biopharmaceuticals's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengdu Olymvax Biopharmaceuticals's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Olymvax Biopharmaceuticals's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Chengdu Olymvax Biopharmaceuticals's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Chengdu Olymvax Biopharmaceuticals Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Chengdu Olymvax Biopharmaceuticals's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Olymvax Biopharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Tianxin Road, High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.olymvax.com

Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.

Executives

Chen Dao Yuan	Core technical personnel
Li Hong Guang	Core technical personnel
Fan Shao Wen	Directors, senior managers
Ma Heng Jun	senior management
Wu Wei	senior management
Fan Fan	Director
Chen Ai Min	Director
Tan Yong	senior management
Lu Lu	Director
Yu Yun Hui	Director
Zhang Li Ying	Core technical personnel
Chen Ke Ping	Core technical personnel
Wu Qiang	Core technical personnel
Yang Feng	Core technical personnel

Chengdu Olymvax Biopharmaceuticals Headlines

No Headlines